A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
Dermatology and Therapy - Germany
doi 10.1007/s13555-018-0252-3
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 27, 2018
Authors
Publisher
Springer Science and Business Media LLC